spacer
The Healthcare Sales & Marketing Network celebrates 22 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Enterin 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 15 Jan 2020
China's HEDY Group Acquires 10 Elekta Cancer Treatment Systems
Devices Oncology
 HSMN NewsFeed - 10 Jan 2020
Inflammatix Announces $32 Million in Series C Funding
Diagnostics Venture Capital
 HSMN NewsFeed - 10 Jan 2020
Relmada Therapeutics Strengthens Financial Operations with Addition of Maged Shenouda as Chief Financial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Jan 2020
Compugen Announces Appointment of Dr. Oliver Froescheis as Senior Vice President, Corporate and Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jan 2020
Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 12 Dec 2019
European Commission Approves EVENITY(R) (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Nov 2019
Olympus Unveils Corporate Strategy
Devices
 HSMN NewsFeed - 18 Oct 2019
Nplate(R) (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Oct 2019
EVENITY(R) (Romosozumab) Receives Positive CHMP Opinion For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Oct 2019
Teijin and NeuroSigma Enter into Exclusive License Agreement
Devices Neurology Licensing
 HSMN NewsFeed - 24 Sep 2019
Artios Pharma Appoints Tania Dimitrova as Chief Business Officer and Expands Presence in the United States
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2019
Amgen To Acquire Otezla(R) For $13.4 Billion In Cash, Or Approximately $11.2 Billion Net Of Anticipated Future Cash Tax Benefits
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 14 Aug 2019
Regeneron Announces Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High Cholesterol
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 7 Aug 2019
Camber Spine Announces Addition of Biologics to Its Portfolio
Devices Orthopaedic Product Launch Distribution
 HSMN NewsFeed - 24 Jul 2019
Exogenesis Corporation Announces the Filing of a 510(k) Pre-Marketing Notification Application with the US Food and Drug Administration for Exogenesis Hernia Mesh
Devices Surgery FDA
 HSMN NewsFeed - 15 Jul 2019
ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Jul 2019
Lannett Enters Into Distribution Agreement For Levothyroxine
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 28 Jun 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Jun 2019
SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2019
Terumo Enhances Coronary Interventional Product Portfolio By Securing Exclusive Global Rights to Orchestra BioMed's Virtue(R) Sirolimus-Eluting Balloon (SEB) through Global Strategic Partnership
Devices Interventional Licensing
 HSMN NewsFeed - 29 May 2019
ReWalk Robotics Receives CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device
Devices Regulatory
 HSMN NewsFeed - 6 May 2019
Portage Announces Change of CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2019
ACell Enters Exclusive Chinese Product Supply and Distribution Agreement for Cytal and MicroMatrix Wound Management Products
Devices Wound Care Distribution
 HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Mar 2019
Micro Interventional Devices(TM), Inc. Enters Strategic Alliance with OSCOR(R), Inc.; Closes Series D Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 28 Feb 2019
Bardy Diagnostics(TM) Announces Expansion into Canadian Market with Distributor JNC Medical
Devices Cardiology Monitoring Distribution
 HSMN NewsFeed - 22 Jan 2019
European Commission Approves BLINCYTO(R) (blinatumomab) In Patients With Philadelphia Chromosome Negative Minimal Residual Disease-Positive B-cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Jan 2019
EVENITY(TM) (romosozumab) Receives Approval In Japan For The Treatment Of Osteoporosis In Patients At High Risk Of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Jan 2019
Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Nov 2018
Rob Fuchs joins ViewRay as Chief Human Resources Officer
Devices Oncology Personnel
 HSMN NewsFeed - 13 Nov 2018
Sobi(TM) to Acquire Synagis(R) US Rights From AstraZeneca - Creates a Platform for Global Growth
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 5 Nov 2018
Biocept Announces New Executive Hires to its Sales and Marketing Organization
Diagnostics Oncology Personnel
 HSMN NewsFeed - 29 Oct 2018
OncoSec Appoints Kellie Malloy Foerter as Chief Clinical Development Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Oct 2018
ViewRay Appoints Industry Veteran James Alecxih as Chief Commercial Officer
Devices Oncology Radiology Personnel
 HSMN NewsFeed - 1 Oct 2018
FDA Approves KYPROLIS(R) (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone (Kd70) For Patients With Relapsed Or Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Sep 2018
Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin(R)) In Canada
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Sep 2018
XACT Robotics Receives CE Mark for Its Robotics Navigation System for Percutaneous Procedures
Devices Interventional Regulatory Venture Capital
 HSMN NewsFeed - 10 Sep 2018
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 5 Sep 2018
Halozyme Names Benjamin Hickey As Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Sep 2018
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Aug 2018
European Commission Approves BLINCYTO(R) (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 Aug 2018
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
Devices Cardiology
 HSMN NewsFeed - 10 Aug 2018
Nuvo Pharmaceuticals(TM) Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 30 Jul 2018
Enzyvant Expands Leadership Team with Appointments of Andrew Dawson and Alex Tracy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2018
OncoSec Appoints Robert W. Ashworth, Ph.D. as Vice President, Regulatory
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Jul 2018
Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE(R) Technology
Biopharmaceuticals Oncology Drug Delivery
 HSMN NewsFeed - 13 Jul 2018
Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY(TM) (romosozumab) To The US FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Jul 2018
FDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 3 Jul 2018
MabVax Therapeutics Grants Exclusive Sublicense to Y-mAbs Therapeutics for Patented Neuroblastoma Vaccine
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 28 Jun 2018
Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jun 2018
Beckman Coulter Diagnostics Receives U.S. FDA 510(k) Clearance for High- sensitivity Access hsTnI Assay
Diagnostics Cardiology FDA
 HSMN NewsFeed - 13 Jun 2018
BridgeBio Pharma Launches CoA Therapeutics to Target Coenzyme-A for Rare Genetic Disorders
Biopharmaceuticals
 HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 May 2018
AbelsonTaylor Hires Amanda Hartzmark as Director of Business Development and Analysis
Personnel
 HSMN NewsFeed - 18 May 2018
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 8 May 2018
NRG(R) Transseptal Needle Associated with a 40% Lower Risk of Silent Cerebral Embolism
Devices Cardiology
 HSMN NewsFeed - 27 Apr 2018
Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia(R) (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Apr 2018
Compugen Announces Exclusive License Agreement With MedImmune for the Development of Bi-Specific and Multi-Specific Antibody Products
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 23 Mar 2018
Amgen Receives Positive CHMP Opinion Recognizing That Repatha(R) (evolocumab) Prevents Heart Attacks And Strokes
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 23 Mar 2018
Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin(R)) For The Treatment Of Three Types Of Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Mar 2018
Cyteir Therapeutics Secures $29 Million Series B to Advance Novel, Molecularly Targeted Therapies for Cancer and Autoimmune Diseases
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 6 Mar 2018
Corin Group Launches Trinity(TM) Dual Mobility System for Hip Replacement at AAOS 2018 Annual Meeting
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 27 Feb 2018
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 23 Feb 2018
Amgen Receives Positive Opinion Expanding Use Of XGEVA(R) (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 6 Feb 2018
Grifols HyperRAB(R) (rabies immune globulin [human]) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Feb 2018
Neovasc Announces Receipt of German NUB Status 1 Designation for Neovasc Reducer(TM) Procedure for Treatment of Refractory Angina
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 22 Jan 2018
Fred Colen Appointed Chief Executive Officer of Neovasc Inc.
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 19 Jan 2018
MyoKardia Announces Appointment of Cynthia Ladd as General Counsel
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 9 Jan 2018
ClearLine MD(TM) Secures $5.5MM Funding for Commercialization of ClearLine IV(TM)
Devices Venture Capital
 HSMN NewsFeed - 5 Jan 2018
FDA Approves XGEVA(R) (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Jan 2018
Recro Pharma Announces Key Executive Promotions to the Financial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Nov 2017
Sumitomo Dainippon Pharma and Angelini Announce Partnership for Commercialization of Latuda(R) (Lurasidone Hydrochloride) in Europe
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 17 Nov 2017
Amgen Launches The ENBREL Mini(TM) Single-Dose Prefilled Cartridge With AutoTouch(TM) Reusable Autoinjector That Is Ergonomically Designed For Patients
Biopharmaceuticals Devices Drug Delivery Product Launch
 HSMN NewsFeed - 14 Nov 2017
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA advisory about deadly risks associated with Kratom
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Nov 2017
Amgen Receives Positive CHMP Opinion To Expand Use Of Nplate(R) (romiplostim) In Pediatric Patients With Chronic Immune Thrombocytopenic Purpura
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Nov 2017
Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Nov 2017
Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to improve FDA review of shared Risk Evaluation and Mitigation Strategies to improve generic drug access
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Nov 2017
Treatments Commence at Two Algerian Hospitals Equipped with Modern Varian Radiotherapy Systems
Devices Oncology
 HSMN NewsFeed - 26 Oct 2017
Teijin Nakashima Medical to Acquire Spinal-related Business of Century Medical
Devices Orthopaedic Distribution Mergers & Acquisitions
 HSMN NewsFeed - 28 Sep 2017
Amgen And AbbVie Agree To Settlement Allowing Commercialization Of AMGEVITA(TM)
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 8 Sep 2017
Eloxx Pharmaceuticals Expands Management Team to Support Rapid Development of Lead Drug Candidate ELX-02 for the Treatment of Rare Genetic Diseases
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Aug 2017
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 15 Aug 2017
Lexicon Pharmaceuticals Reports Additional Positive Data From Pivotal Phase 3 inTandem2 Study Of Sotagliflozin
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 14 Aug 2017
Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR
Diagnostics Oncology Distribution
 HSMN NewsFeed - 7 Aug 2017
Alkahest Appoints Helen Jenkins as Chief Operating Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Jul 2017
Amgen and Allergan Submit Biosimilar Biologics License Application for ABP 980 to US Food and Drug Administration
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 17 Jul 2017
Amgen And UCB Provide Update On Regulatory Status Of EVENITY(TM) (romosozumab) In The US
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jul 2017
Enterin Inc. Raises $12.7 Million in Series A Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 7 Jul 2017
CathVision Raises Venture Funding to Market New EP Recording System
Devices Cardiology Venture Capital
 HSMN NewsFeed - 19 Jun 2017
FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA(R) (denosumab) To Include Multiple Myeloma Patients
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Jun 2017
New Safety and Long-Term Efficacy Data from Baricitinib Clinical Trials in Patients with Moderate-to-Severe Rheumatoid Arthritis Presented at EULAR 2017
Biopharmaceuticals
 HSMN NewsFeed - 9 Jun 2017
Lexicon Pharmaceuticals Reports Positive Top-Line Results In Phase 3 inTandem3 Study For Sotagliflozin In Patients With Type 1 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 8 Jun 2017
Merrimack Announces Expansion of Senior Management Team with Appointment of Sergio Santillana as Chief Medical Officer and Ellen Forest as Head of Human Resources
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 May 2017
Amgen And UCB Announce Top-Line Phase 3 Data From Active-Comparator Study Of EVENITY(TM) (Romosozumab) In Postmenopausal Women With Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 18 May 2017
Amgen Submits Biologics License Application To The FDA For Erenumab
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 24 Apr 2017
Medtronic Announces Most Advanced StealthStation(TM) for Neurosurgery
Devices Neurosurgery Product Launch
 HSMN NewsFeed - 20 Apr 2017
Japan's Sawai Pharmaceutical to Acquire the Generics Business of U.S. Upsher-Smith Laboratories
Biopharmaceuticals Generics Acquisitions
 HSMN NewsFeed - 13 Apr 2017
Arbutus Injunction Survives Attempted Appeal by Acuitas
Biopharmaceuticals Litigation
 HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 13 Mar 2017
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2017
CTI BioPharma Announces Appointment of Hematology/Oncology Clinical Expert Adam Craig, M.D., Ph.D., as President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Feb 2017
Repatha(R) (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 1 Feb 2017
Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
Devices Dermatology Personnel
 HSMN NewsFeed - 23 Jan 2017
Alkahest Appoints Sam Jackson, M.D., MBA as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jan 2017
MindChild Medical, Inc. Announces Clearance of a 510(k) Pre-Marketing Notification with the US Food and Drug Administration (FDA) for the MERIDIAN(TM) M110 Fetal Monitoring System
Devices Monitoring FDA
 HSMN NewsFeed - 11 Jan 2017
Study Results Published in the Journal of the American Medical Association Show Amgen's Parsabiv(TM) (Etelcalcetide) Significantly Reduced Serum Parathyroid Hormone in Adults With Secondary Hyperparathyroidism on Hemodialysis
Biopharmaceuticals
 HSMN NewsFeed - 9 Jan 2017
Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Jan 2017
CEO Geoffrey McDonough to Leave Sobi
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2017
Zogenix Announces CFO Transition
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Dec 2016
Health Canada approves STELARA(R) for the treatment of adults with moderately to severely active Crohn's disease
Biopharmaceuticals Gastroenterology Regulatory
 HSMN NewsFeed - 17 Nov 2016
Regeneron and Sanofi Announce Praluent(R) (alirocumab) Cardiovascular Outcomes Trial Will Continue as Planned Following Interim Analysis
Biopharmaceuticals
 HSMN NewsFeed - 7 Nov 2016
Philips and Masimo Sign Multi-Year Business Partnership Agreement in Patient Monitoring and Select Therapy Solutions
Devices Monitoring
 HSMN NewsFeed - 2 Nov 2016
Verastem Licenses Duvelisib from Infinity Pharmaceuticals
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 28 Oct 2016
AliveCor Unveils Medical Grade Mobile App to Manage Top Risk Factors for Stroke
Devices Cardiology
 HSMN NewsFeed - 12 Oct 2016
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Sep 2016
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Sep 2016
Insmed Appoints Roger Adsett as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Sep 2016
Endo Names Paul Campanelli President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2016
aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J. King, PhD, as Senior Vice President, Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2016
Installation Initiated for Elekta’s High-Field MR-Adaptive Linear Accelerator at Froedtert & the Medical College of Wisconsin Clinical Cancer Center
Devices Oncology
 HSMN NewsFeed - 9 Sep 2016
Philips Introduces Next Generation Interventional Oncology Solution OncoSuite* for Advanced Tumor Analysis and Therapy in Europe
Devices Interventional Oncology Product Launch
 HSMN NewsFeed - 7 Sep 2016
AMAG Pharmaceuticals Appoints Tony Casciano as Senior Vice President of Hematology/Oncology Sales and Marketing
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Sep 2016
OncoSec Appoints Sharron Gargosky, PhD, to Chief Clinical and Regulatory Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Aug 2016
Regeneron and Sanofi Present Positive Phase 3 Investigational Data for Praluent(R) (alirocumab) Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 29 Aug 2016
New Repatha(R) (evolocumab) Analyses Show Efficacy and Safety Across Risk Groups in Results Presented at ESC Congress 2016
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Aug 2016
Amgen Provides Update On Status Of Parsabiv(TM) (Etelcalcetide) New Drug Application (NDA) Submitted To The U.S. Food And Drug Administration (FDA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Aug 2016
Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 28 Jul 2016
Orthofix Announces Japanese Approval and Market Launch of PHOENIX Minimally Invasive Spinal Fixation System
Devices Orthopaedic Regulatory Product Launch
 HSMN NewsFeed - 25 Jul 2016
Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever
Devices Interventional Neurology Personnel
 HSMN NewsFeed - 20 Jul 2016
Cellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Jul 2016
AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access & Corporate Accounts
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2016
Recro Pharma Appoints Michael Celano as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jul 2016
European Commission Approves Extended Indication For Amgen's Kyprolis(R) (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Jun 2016
Keryx Biopharmaceuticals Appoints Two New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2016
ContraVir Completes Merger with Ciclofilin Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 May 2016
Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 17 May 2016
Lightpoint Medical Announces Exclusive Global License Agreement With the University of Arizona to Develop Molecular Imaging Technology
Devices Radiology Licensing
 HSMN NewsFeed - 6 Apr 2016
Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Mar 2016
Zavante Therapeutics Closes $45 Million Series A Financing In Support Of U.S. Development For A First-In-Class Injectable Antibiotic
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 21 Mar 2016
Amgen And UCB Announce Positive Top-Line Results From Phase 3 Study Evaluating Romosozumab In Men With Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2016
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 3 Mar 2016
Kris Peterson to Join Paratek Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Feb 2016
Amgen And UCB Announce Positive Top-Line Results From The Phase 3 Study Of Romosozumab In Postmenopausal Women With Osteoporosis
Biopharmaceuticals
 HSMN NewsFeed - 10 Feb 2016
Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Feb 2016
Amarantus Requests Rare Pediatric Disease Designation from US FDA for MANF in the Treatment of Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 4 Feb 2016
Phase 3 Study of BLINCYTO(R) (Blinatumomab) Met Primary Endpoint Of Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Feb 2016
Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-3 Trial Of Repatha(R) (Evolocumab) In Statin-Intolerant Patients With High Cholesterol
Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2016
Hansen Medical(R) Announces FDA Clearance of the Magellan(TM) Robotic Catheter eKit
Devices Interventional FDA
 HSMN NewsFeed - 1 Feb 2016
Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2016
Amgen's Repatha(R) (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Jan 2016
Hansen Medical Provides Corporate Update of Key Near-Term Clinical, Regulatory and Commercial Events
Devices Cardiology
 HSMN NewsFeed - 14 Jan 2016
Hansen Medical Announces Exploration of Strategic Alternatives
Devices Cardiology
 HSMN NewsFeed - 14 Jan 2016
Avita Medical Appoints Distributors in Japan and South Korea
Devices Wound Care Distribution
 HSMN NewsFeed - 29 Dec 2015
Amarantus Requests Rare Pediatric Disease and Orphan Drug Designations from US FDA for Engineered Skin Substitute in the Treatment of Giant Congenital Melanocytic Nevi
Devices Regenerative Medicine Dermatology FDA
 HSMN NewsFeed - 21 Dec 2015
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
Biopharmaceuticals Licensing
 HSMN NewsFeed - 18 Dec 2015
European Commission Approves Amgen's IMLYGIC(TM) (talimogene laherparepvec) As First Oncolytic Immunotherapy In Europe
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Dec 2015
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2015
Otonomy Announces FDA Approval of OTIPRIO(TM) for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement Surgery
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Dec 2015
Ignyta Appoints William Mccarthy as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Dec 2015
Amgen's First Biosimilar Marketing Authorization Application Submitted To European Medicines Agency For ABP 501
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Nov 2015
European Commission Approves Amgen's BLINCYTO(R) (blinatumomab) for the Treatment of Adults with Philadelphia Chromosome-Negative Relapsed or Refractory B-precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Oct 2015
Arvinas Secures $41.6M Series B Financing - Appoints New Board Members
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Oct 2015
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
Biopharmaceuticals Urology FDA
 HSMN NewsFeed - 28 Sep 2015
Zafgen Announces Transition of Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Sep 2015
KARL STORZ’s New FLEX-GUARD System is Designed to Reduce Repair Costs of Flexible Ureterscopes
Devices Urology Product Launch
 HSMN NewsFeed - 17 Sep 2015
Ignyta Appoints Igor Bilinsky as General Manager, Immuno-Oncology and Senior Vice President, Special Operations
Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 16 Sep 2015
Amgen To Acquire Privately-Held Dezima Pharma
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 15 Sep 2015
Marathon Pharmaceuticals Names Dr. Jordan Dubow Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2015
Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha(TM) (Evolocumab)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 8 Sep 2015
Lombard Medical Names David Milne to Board of Directors
Devices Interventional Personnel
 HSMN NewsFeed - 2 Sep 2015
Ascletis Secures US$35 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Aug 2015
Theragen LLC Announces Acquisition of Neurotech North America
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 11 Aug 2015
Rich Pharmaceuticals, Inc. Appoints Richard Salvador, Ph.D., Research & Development Expert, To Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Aug 2015
InteloMed, Inc. Appoints Jill Schiaparelli President and Chief Executive Officer
Devices Cardiology Monitoring Personnel
 HSMN NewsFeed - 16 Jul 2015
AMRI Acquires Gadea Pharmaceutical Group
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Jun 2015
Cellectar Appoints Industry Veteran Jim Caruso President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Jun 2015
Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 May 2015
Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2015
Cortendo AB: Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing
Biopharmaceuticals Acquisitions Licensing Venture Capital
 HSMN NewsFeed - 23 Apr 2015
Clear Guide Medical Receives CE Mark on the Clear Guide ONE
Devices Interventional Regulatory
 HSMN NewsFeed - 20 Apr 2015
MindChild Medical, Inc. Announces clearance of a 510(k) Pre-Marketing Notification Application with the US Food and Drug Administration for the MERIDIAN(TM) M100 Line of Non-Invasive Fetal Heart Rate Monitors
Devices Monitoring FDA
 HSMN NewsFeed - 10 Apr 2015
Radius Health Today Announced That it Has Appointed Brent Hatzis-Schoch as Senior Vice President and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2015
European Commission Approves Amgen's Vectibix(R) (panitumumab) As First-Line Treatment In Combination With FOLFIRI Chemotherapy For Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Apr 2015
AMAG Pharmaceuticals Announces New Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2015
Tyrogenex, Xcovery Appoint Michael Webb as President and Chief Executive Officer
Biopharmaceuticals Ophthalmology Oncology Personnel
 HSMN NewsFeed - 17 Feb 2015
Regen BioPharma, Inc. Expands Management Team With the Addition of New CFO Todd Caven
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 5 Feb 2015
Hansen Medical Announces Expanded Protocol for the ARTISAN AF IDE Study
Devices Cardiology FDA
 HSMN NewsFeed - 28 Jan 2015
University of Oklahoma Proton Therapy System Enters Clinical Commissioning
Devices Oncology
 HSMN NewsFeed - 20 Jan 2015
NovaBay Expands Sales Force for Avenova
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 30 Oct 2014
Hansen Medical Announces Global Launch of the Sensei X2(R) Robotic System
Devices Cardiology Product Launch
 HSMN NewsFeed - 9 Oct 2014
Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Sep 2014
OncoSec Medical Appoints Dr. Mai H. Le to Position of Chief Medical Officer and Names Dr. Robert H. Pierce as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Sep 2014
Cordis Corporation Launches INCRAFT(R) AAA Stent Graft System for Treatment of Abdominal Aortic Aneurysms (AAA)
Devices Interventional Product Launch
 HSMN NewsFeed - 3 Sep 2014
Intensity Therapeutics, Inc. Appoints Ian B. Walters M.D., MBA as Vice President and Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Sep 2014
Eisai Sells U.S. Rights to Zonegran(R) (zonisamide) Capsules to Concordia Pharmaceuticals Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 Aug 2014
AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Aug 2014
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2014
Aqua Pharmaceuticals, LLC Announces the U.S. Food and Drug Administration (FDA) Approval of ACTICLATE(TM) (doxycycline hyclate USP) Tablets, 150 mg and 75 mg
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Jul 2014
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR(R) (sorafenib) in Patients with Advanced Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Jul 2014
Teleflex Receives FDA Clearance for ARROW-Clark(TM) VectorFlow(TM) Chronic Hemodialysis Catheter
Devices FDA
 HSMN NewsFeed - 2 Jun 2014
Omeros Receives FDA Approval of Omidria(TM) for Use in Cataract and Other Intraocular Lens Replacement Procedures
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 28 May 2014
Hansen Medical Announces First Clinical Cases in United States With New Magellan(TM) 6Fr Robotic Catheter
Devices Interventional
 HSMN NewsFeed - 9 Apr 2014
Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2014
Omnis Health Introduces EmbracePro(TM) – Professional Blood Glucose Meter
Devices Monitoring Endocrinology Product Launch
 HSMN NewsFeed - 1 Apr 2014
Cubist Appoints Robert J. Perez to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2014
AMRI to Acquire Cedarburg Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Mar 2014
Healthcare Startup Augmedix Announces $3.2 Million in Venture Funding
Devices Venture Capital
 HSMN NewsFeed - 11 Mar 2014
Bayer and Onyx Report Phase 3 Study Results of NEXAVAR(R) (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Mar 2014
Heat Biologics, Inc. Appoints Taylor H. Schreiber, M.D., PH.D. as Vice President of Research and Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 13 Feb 2014
Regulus Appoints Head of Regulus microMarkers(TM) R&D Division
Biopharmaceuticlas Personnel
 HSMN NewsFeed - 12 Feb 2014
DEKA Medical Receives FDA Clearance for the Synchro REPLA:Y
Devices Dermatology FDA
 HSMN NewsFeed - 10 Feb 2014
Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Feb 2014
Regulus Strengthens Executive Management Team with Addition of David Szekeres as Chief Business Officer and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jan 2014
Abyrx(TM), Inc. Announces Option to Acquire Haibo Biotechnology Institute's Soft Tissue Hemostat Technology Platform
Devices Surgery Acquisitions
 HSMN NewsFeed - 20 Jan 2014
Hansen Medical's Magellan(TM) Robotic System to Be Featured in Three Live Cases at 26th Annual International Symposium on Endovascular Therapy
Devices Interventional
 HSMN NewsFeed - 13 Jan 2014
Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 7 Jan 2014
AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
Velocity Pharmaceutical Development Announces Appointment of Stuart Sedlack as Senior Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Dec 2013
Miraculins and Cachet Pharmaceutical Agree to 30-Day Extension on Letter of Intent to Continue Negotiation of Licensing Rights for SCOUT DS(R) Diabetes Test in China
Diagnostics Endocrinology Licensing
 HSMN NewsFeed - 17 Dec 2013
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Dec 2013
EMD Serono's Redesigned Fertility Pen Available for Distribution in US
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 13 Dec 2013
Theratechnologies Regains U.S. Marketing Rights to EGRIFTA(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Dec 2013
Kamada Announces Appointment of Amir London as Senior Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Dec 2013
Boston Scientific and The Medicines Company Announce U.S. Co-Promotion Agreement for Promus PREMIER(TM) Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Dec 2013
PaxVax Secures $22 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Dec 2013
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 2 Dec 2013
InspireMD Appoints Rick Olson as Vice President of Global Sales Operations
Devices Interventional Personnel
 HSMN NewsFeed - 20 Nov 2013
MAQUET Cardiovascular Announces Study Results Demonstrating HEARTSTRING(R) Device Associated with Significant Reduction in Coronary Artery Bypass Stroke Risk
Devices Surgery Cardiology
 HSMN NewsFeed - 5 Nov 2013
First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Hot Flashes Now Available by Prescription in U.S. Pharmacies
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Oct 2013
AMAG Pharmaceuticals Appoints Robert F. Kaper, M.D. as Senior Vice President of Medical and Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2013
Rigel Provides Pipeline Update
Biopharmaceuticals
 HSMN NewsFeed - 22 Oct 2013
Monteris Medical Announces $13 Million Financing
Devices Neurosurgery Venture Capital
 HSMN NewsFeed - 15 Oct 2013
Immune Pharmaceuticals Announces Changes to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Oct 2013
Personalis Closes $22M Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 1 Oct 2013
Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Sep 2013
Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Sep 2013
Heat Biologics Appoints Louis C. Bock to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Sep 2013
Arrowhead Promotes David Lewis to Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2013
ALung Technologies Raises $15.8 Million in Series B-1 Financing
Devices Venture Capital
 HSMN NewsFeed - 28 Aug 2013
Auxilium Receives Notification of XIAFLEX(R) PDUFA Extension
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Aug 2013
Advaxis Appoints Daniel J. O’Connor President and CEO and Elects Dr. James Patton Non-Executive Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2013
Hansen Medical Enters Into Agreement With Investors to Receive up to $93 Million in Equity Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 23 Jul 2013
AMAG Pharmaceuticals Appoints Carol Satler, M.D., Ph.D. as Senior Vice President of Medical and Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jul 2013
Hansen Medical and Philips Reinforce Collaboration in Robotic Systems for Endovascular Interventions
Devices Interventional Radiology
 HSMN NewsFeed - 26 Jun 2013
Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercialization of PLX Cells for the Treatment of CLI and IC in South Korea
Regenerative Medicine Licensing
 HSMN NewsFeed - 24 Jun 2013
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2013
FDA Approves Amgen's XGEVA(R) (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Jun 2013
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jun 2013
Reverse Medical Corporation Announces Strategic Alliance in Japan
Devices Interventional Distribution
 HSMN NewsFeed - 5 Jun 2013
Peter J. Carbonaro Joins Atossa Genetics as Senior Vice President of Operations
Diagnostics Personnel
 HSMN NewsFeed - 29 May 2013
Amgen And Astellas Announce Japan Alliance
Biopharmaceuticals
 HSMN NewsFeed - 21 May 2013
Accumed Radial Systems, LLC Names Michael Pisano, PhD, as President and Chief Executive Officer
Devices Interventional Personnel
 HSMN NewsFeed - 6 May 2013
Hansen Medical to Exhibit Magellan(TM) Robotic System at 8th Annual European Symposium of Vascular Biomaterials in France
Devices Interventional
 HSMN NewsFeed - 10 Apr 2013
Pfizer’s Palbociclib (PD-0332991) Receives Food And Drug Administration Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Apr 2013
Teva Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2013
Aquinox Pharmaceuticals Completes US $18 million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 18 Mar 2013
Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2013
Boston Therapeutics Appoints Peter Sheehan, M.D. as Medical Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2013
EnteroMedics Names Greg S. Lea Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 14 Feb 2013
Hansen Medical Appoints Will Sutton as Chief Operating Officer Responsible for Engineering and Manufacturing
Devices Personnel
 HSMN NewsFeed - 7 Feb 2013
Amgen Outlines Long-Term Strategy
Biopharmaceuticals
 HSMN NewsFeed - 4 Feb 2013
MGC Diagnostics Corporation Appoints Wesley W. Winnekins as Executive Vice President, Finance and Corporate Development; Winnekins will also serve as Chief Financial Officer
Diagnostics Personnel
 HSMN NewsFeed - 1 Feb 2013
NeuroVive Appoints Chief Operating Officer
Biopharmaceuticals Cardiology Neurology Personnel
 HSMN NewsFeed - 29 Jan 2013
Spectranetics Announces Expansion Into Japan Peripheral Intervention Market
Devices Interventional Regulatory
 HSMN NewsFeed - 16 Jan 2013
Hansen Medical Names Robert Cathcart Senior Vice President of Global Sales
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 3 Jan 2013
Given Imaging Launches New ManoView(TM) ESO v3.0 Software
Devices Gastroenterology
 HSMN NewsFeed - 28 Dec 2012
Perrigo Company Acquires Remaining Stake in Cobrek Pharmaceuticals, Inc. for Approximately $45 Million
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 21 Dec 2012
Christopher S. Destro Joins Atossa Genetics as Vice President of Sales and Marketing
Diagnostics Oncology Personnel
 HSMN NewsFeed - 18 Dec 2012
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Dec 2012
Lenstec Expands Precision Line of IOLs With New Softec HD Oval Intraocular Lens
Devices Ophthalmology
 HSMN NewsFeed - 3 Dec 2012
Volcano Corporation Announces Agreement To Acquire Crux Biomedical
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 29 Nov 2012
Rib-X Pharmaceuticals Closes First Tranche in $67.5 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Nov 2012
Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter into Agreement to Combine Businesses
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 15 Nov 2012
Targacept Appoints Stephen A. Hill, M.D., President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Oct 2012
Hansen Medical Announces Expanded Agreement With Intuitive Surgical
Devices Interventional Surgery Licensing
 HSMN NewsFeed - 31 Oct 2012
Inspiration Biopharmaceuticals Files for Chapter 11 Protection in Order to Pursue a Broad Strategic Transaction
Biopharmaceuticals
 HSMN NewsFeed - 1 Oct 2012
XDx Appoints Peter Maag as President and CEO
Diagnostics Personnel
 HSMN NewsFeed - 30 Aug 2012
Aerpio Therapeutics Completes $27 Million Series A Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 30 Aug 2012
Genmab Enters Worldwide Agreement With Janssen for Daratumumab
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 15 Aug 2012
Astellas Pharma Europe Ltd. Appoints Dr Susan Wood as Senior Director, Market Access
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2012
Mevion Medical Systems Delivers the MEVION S250 Superconducting Synchrocyclotron to Robert Wood Johnson University Hospital
Devices Oncology
 HSMN NewsFeed - 16 Jul 2012
Coferon, Inc. Announces $12 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 2 Jul 2012
GSK and Theravance Announce Positive Results From Four Pivotal Phase III Studies for Once-Daily LAMA/LABA (UMEC/VI) in COPD
Biopharmaceuticals
 HSMN NewsFeed - 25 Jun 2012
Paragonix Technologies Inc., Announces Appointment of Leonard A. R. Golding, MB, BS, FRACS, FRCS(C), FACC as Chief Medical Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 29 May 2012
Watson Announces Lidoderm(R) Patent Challenge Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 22 May 2012
AngioDynamics Completes Acquisition of Navilyst Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 3 May 2012
Five Prime Therapeutics Announces the Promotion of Aron Knickerbocker to Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2012
Gentium Appoints PharmaSwiss, S.A. as Exclusive Distributor of Defibrotide in Central and Eastern European Countries
Biopharmaceuticals Distribution
 HSMN NewsFeed - 1 May 2012
Dr. Frank Basile Joins Miraca Life Sciences as President and Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 26 Apr 2012
Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 24 Apr 2012
Orthofix International Announces Signing of Agreement to Sell Sports Medicine Business Unit to Water Street Healthcare Partners
Devices Acquisitions
 HSMN NewsFeed - 10 Apr 2012
Amgen to Acquire Privately Held KAI Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Apr 2012
Biomet Announces Offer to Acquire DePuy Trauma Business
Devices Orthopaedic Neurosurgery Acquisitions
 HSMN NewsFeed - 27 Mar 2012
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 20 Mar 2012
Benvenue Medical Starts Enrolling Patients in the Post-Market LIFT Study on the Luna Interbody Spacer System for Degenerative Disc Disease
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 28 Feb 2012
Michael L. Eagle Appointed to Hansen Medical's Board of Directors
Devices Cardiology Personnel
 HSMN NewsFeed - 22 Feb 2012
Teleflex Signs Regional Anesthesia Agreement with German Asklepios Hospital Group for ambIT(R) PCA Pump
Devices
 HSMN NewsFeed - 20 Feb 2012
Theragenics Acquires Core Oncology’s Prostate Brachytherapy Customer Base
Devices Oncology Acquisitions
 HSMN NewsFeed - 14 Feb 2012
Biogen Idec to Acquire Stromedix
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Feb 2012
PaxVax Expands Executive Management Team
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 6 Feb 2012
MindChild Medical, Inc. Announces Filing of a 510(k) Pre-Marketing Notification Application with the US Food and Drug Administration for the MERIDIANTM Line of Non-Invasive Fetal Heart Rate Monitors
Devices Monitoring Cardiology FDA
 HSMN NewsFeed - 26 Jan 2012
Amgen to Acquire Micromet
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 25 Jan 2012
ZELTIQ(R) Initiates Patent Infringement Lawsuit Against Clinipro
Devices Litigation
 HSMN NewsFeed - 20 Jan 2012
Hartford Hospital Selected as a Hansen Medical "Center of Excellence" for Sensei(R) X Robotic Catheter Platform
Devices Cardiology
 HSMN NewsFeed - 9 Jan 2012
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies for Once-Daily Relovair(TM)* in COPD and Asthma
Biopharmaceuticals
 HSMN NewsFeed - 6 Jan 2012
Hansen Medical to Highlight Sensei(R) X Robotic Catheter System and Related Products at the Boston Atrial Fibrillation Symposium
Devices Cardiology
 HSMN NewsFeed - 28 Dec 2011
KCI Announces Transition to New Executive Leadership
Devices Wound Care Personnel
 HSMN NewsFeed - 6 Dec 2011
Amgen and FDA Agree to Modify Nplate(R) (Romiplostim) Risk Evaluation and Mitigation Strategy
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Nov 2011
Agios Secures $78 Million in Oversubscribed Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 14 Nov 2011
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA(TM*)) in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Oct 2011
Arrowhead Research Appoints Bruce Given M.D. Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Oct 2011
Tranzyme Pharma Names Former Gilead Executive Franck Rousseau, M.D. Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2011
Lilly Announces Changes in Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2011
Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery
Devices Surgery Monitoring
 HSMN NewsFeed - 19 Sep 2011
FDA Approves New Indications for Prolia(R) (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Sep 2011
CSA Medical Appoints Wendelin Maners VP of Emerging Therapies
Devices Personnel
 HSMN NewsFeed - 12 Sep 2011
InterMune Announces Launch of Esbriet(R) (pirfenidone) in Germany
Biopharmaceuticals
 HSMN NewsFeed - 12 Sep 2011
SuperGen, Inc. Changes Name to Astex Pharmaceuticals, Inc., Announces New Stock Ticker Symbol and New Website
Biopharmaceuticals
 HSMN NewsFeed - 8 Sep 2011
Nexera Medical, Inc. Announces That It Plans to Submit New Data to the U.S. Food and Drug Administration (FDA) to Amend Its Current 510k Medical Device Clearance to Include Certain Strains of Viruses
Devices
 HSMN NewsFeed - 6 Sep 2011
NIH-Funded Study Demonstrates That Patients Receiving New CPR Devices (ResQPOD(R) and ResQPump) and Cooling Have Improved Long-Term Brain Function Following Cardiac Arrest
Devices Cardiology
 HSMN NewsFeed - 17 Aug 2011
Labopharm Inc. Enters Into an Agreement to Be Acquired by Paladin Labs Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Aug 2011
Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2011
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 2 Jun 2011
GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD
Biopharmaceuticals
 HSMN NewsFeed - 25 May 2011
Watson Acquires Specifar Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 May 2011
VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
Biopharmaceuticals Urology Oncology
 HSMN NewsFeed - 20 May 2011
Amgen Receives CHMP Positive Opinion for XGEVA (Denosumab) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Apr 2011
Kelyniam Receives FDA 510(k) Clearance to Market Cranial Implants
Devices Neurosurgery FDA
 HSMN NewsFeed - 18 Apr 2011
Baxter Announces the Acquisition of Prism Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Apr 2011
Benvenue Medical Closes $35.5 Million Series C Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 11 Apr 2011
Novartis Therapy Gilenya Reduced the Risk of MS Disability Progression Regardless of Treatment History or Disease Severity, New Analysis Shows
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Mar 2011
iTech Medical Appoints Warren G. Baker as Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 29 Mar 2011
Elekta Software Making Strong Inroads in Clinics Providing Proton Therapy for Patients with Cancer
Devices Oncology
 HSMN NewsFeed - 23 Mar 2011
Access Pharmaceuticals Appoints Industry Executive Anthony Mottola as Vice President of Managed Care and Market Access
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 18 Mar 2011
Utah Medical Products, Inc. Acquires Femcare Group Limited
Devices Mergers & Acquisitions
 HSMN NewsFeed - 18 Mar 2011
Amgen Statement on CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 15 Mar 2011
Argon Medical Devices Announces Exclusive License and Distribution Agreement for Option Retrievable Inferior Vena Cava Filter
Devices Distribution Licensing
 HSMN NewsFeed - 3 Mar 2011
BoneGrafix Moves Forward with Development of Next Generation Bone Repair Products
Devices Orthopaedic
 HSMN NewsFeed - 3 Mar 2011
InterMune Receives European Union Approval for Esbriet(R) (pirfenidone)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 14 Feb 2011
ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Jan 2011
Ligand Acquires CyDex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Jan 2011
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Jan 2011
St. Jude Medical Reaches Settlement with United States Department of Justice
Devices Litigation
 HSMN NewsFeed - 20 Jan 2011
EDAP Continues Its Growth Strategy; Enters New Major Market for Lithotripsy
Devices Urology
 HSMN NewsFeed - 11 Jan 2011
Lilly and Boehringer Ingelheim Announce Strategic Alliance to Bring New Diabetes Treatments to Patients Worldwide
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 5 Jan 2011
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2010
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet (Pirfenidone) in Europe
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2010
Pier Pharmaceuticals Names Peter Letendre as Chief Executive Officer, President and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2010
InterMune Announces Positive Opinion for Approval of Esbriet (Pirfenidone) in European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 Dec 2010
iCAD to Acquire Xoft, Inc.
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 15 Dec 2010
Orthofix International Announces Reorganization And Settlement with NuVasive and Osiris Therapeutics
Devices Orthopaedic Neurosurgery Litigation
 HSMN NewsFeed - 13 Dec 2010
XGEVA (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2010
Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Dec 2010
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Nov 2010
OncoGenex Pharmaceuticals Names Michelle Burris Executive Vice President, Operations and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2010
Endologix to Acquire Nellix
Devices Interventional Mergers & Acquisitions
 HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Oct 2010
Catabasis Pharmaceuticals Appoints Michael Curtis, Ph.D., as Vice President, Product Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2010
Natus Acquires Medix - Leading Newborn Care Company in Latin America
Devices Mergers & Acquisitions
 HSMN NewsFeed - 31 Aug 2010
Dr. Les Paul Joins Caris Life Sciences as Senior Vice President, Medical Affairs
Diagnostics Personnel
 HSMN NewsFeed - 29 Aug 2010
sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Aug 2010
Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with Procter & Gamble
Biopharmaceuticals
 HSMN NewsFeed - 24 Aug 2010
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
Biopharmaceuticals Distribution
 HSMN NewsFeed - 26 Jul 2010
Roche Receives FDA Clearance for CoaguChek XS Pro system With Bar Code Reader for PT/INR Testing at the Point of Care
Diagnostics FDA
 HSMN NewsFeed - 15 Jul 2010
Adolor Corporation Announces Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 14 Jul 2010
CardioGenics And Merck In Second Product Agreement
Diagnostics Cardiology
 HSMN NewsFeed - 14 Jul 2010
Former Pfizer Senior Vice President Named CEO of Berlin Pharmaceutical Industry in a Partnership to Diversify and Expand Company Business in Asia
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jun 2010
Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2010
SURGIMESH Surgical Implants Expands Distribution Coverage Across U.S. as Adoption Increases Significantly and Hernia Mesh Market Grows at Rapid Pace
Devices Surgery Distribution
 HSMN NewsFeed - 16 Jun 2010
Tranzyme Pharma and Norgine Sign License Agreement for Late-Stage Development Product, Ulimorelin (TZP-101), in Europe and Other Select Regions
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Jun 2010
Agile Therapeutics Secures $45M in Series B Funding to Progress Lead Contraceptive Patch, AG200-15, Through NDA Filing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Jun 2010
FDA Approves Amgen's Prolia(TM) (Denosumab) for Treatment of Postmenopausal Women With Osteoporosis at High Risk for Fracture
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 May 2010
Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 May 2010
Covidien Enters Hemorrhoidopexy Market with New Hemorrhoid Stapling Technology
Devices
 HSMN NewsFeed - 10 May 2010
AngioDynamics Launches Improved Centros(R) Self-Centering Hemodialysis Catheter
Devices
 HSMN NewsFeed - 27 Apr 2010
MAQUET Cardiovascular Announces Study Results Showing Significantly Reduced Stroke Rate In Coronary Artery Bypass Patients When Aortic Clamping is Avoided
Devices Cardiology Surgery
 HSMN NewsFeed - 13 Apr 2010
Entest Biomedical Announces Intent to Acquire Medistem
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 10 Apr 2010
First Comprehensive LASIK Treatment of Astigmatism Approved by the FDA
Devices Ophthalmology FDA
 HSMN NewsFeed - 7 Apr 2010
Torax Medical Receives CE Mark for Its LINX(R) Anti-Reflux Treatment
Devices Gastroenterology Regulatory
 HSMN NewsFeed - 1 Apr 2010
MDRNA, Inc. Acquires Cequent Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Mar 2010
Cortex Sells Selected AMPAKINE Compounds and Rights to Respiratory Depression Indication to Biovail
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 24 Mar 2010
CryoLife Withdraws Its Proposal to Acquire Medafor
Devices Mergers & Acquisitions
 HSMN NewsFeed - 18 Mar 2010
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2010
Illumina and Glenn Close Announce the First Full Coverage DNA Sequencing of a Named Female
Diagnostics
 HSMN NewsFeed - 10 Mar 2010
KCI Wins Patent Case against Smith & Nephew
Devices Wound Care Litigation
 HSMN NewsFeed - 8 Mar 2010
X-spine Announces Exclusive License with Gamma Spine for Minimally-Invasive Spinal Technology
Devices Orthopaedic Neurosurgery Licensing
 HSMN NewsFeed - 3 Mar 2010
Covidien Announces Preferred Vendor Partnership with OSF Healthcare System for Nellcor OxiMax Pulse Oximetry Products
Devices Monitoring Group Purchasing
 HSMN NewsFeed - 1 Mar 2010
ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2010
FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Feb 2010
AstraZeneca and Rigel Pharmaceuticals Sign Worldwide License Agreement for Late-Stage Development Product -- Fostamatinib Disodium (R788) -- for the Treatment of Rheumatoid Arthritis (RA)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Feb 2010
Denosumab Demonstrated Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Feb 2010
Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
Devices Monitoring Endocrinology Personnel
 HSMN NewsFeed - 21 Jan 2010
Amgen Presents Complete Results From Two Pivotal Phase 3 Studies of Vectibix(R) at Gastrointestinal Cancers Symposium
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Jan 2010
Abaxis Receives FDA 510K Clearance for a New
Diagnostics FDA
 HSMN NewsFeed - 14 Jan 2010
Adolor Corporation Announces Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jan 2010
Alnylam Provides Key Goals and Guidance for Next 12 to 18 Months
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2010
Dr. Mark W. Schwartz Joins Apthera as President & CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Jan 2010
Pieris Appoints a New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Dec 2009
Proteonomix, Inc. (PROT) Announces Change in Officers/Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Dec 2009
Trimeris Announces That Arigene Intends to Terminate Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Dec 2009
Professor Riccardo Lencioni Joins Delcath Systems' Scientific Advisory Board
Devices Personnel
 HSMN NewsFeed - 21 Dec 2009
Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 16 Dec 2009
Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer's Treatment and CDA Disease
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 14 Dec 2009
Pathway Medical Technologies Receives CE Mark for the Jetstream G2 NXT
Devices Interventional Regulatory
 HSMN NewsFeed - 14 Dec 2009
Cubist Pharmaceuticals to Acquire Calixa Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Dec 2009
Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Dec 2009
La Jolla Pharmaceutical Company Announces Signing of Definitive Merger Agreement With Adamis Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Dec 2009
Infinity Names Adelene Q. Perkins Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2009
NormOxys Appoints Industry Veteran and Recognized Neuroscience Expert, Martin Tolar, MD, PhD, as Company's CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2009
Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 1 Dec 2009
GE Healthcare Acquires Living Independently Group Inc.
Devices Monitoring Mergers & Acquisitions
 HSMN NewsFeed - 30 Nov 2009
Medipattern and Sentinelle Medical Inc. Announce Breast MRI Development Partnership
Devices Radiology Distribution
 HSMN NewsFeed - 27 Nov 2009
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Nov 2009
Delcath Systems Reports Substantial Progress
Devices Oncology
 HSMN NewsFeed - 5 Nov 2009
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Nov 2009
Arrowhead Subsidiary Calando Pharmaceuticals Expands Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2009
Delcath Systems Completes Executive Management Team with Strategic New Hires
Devices Personnel
 HSMN NewsFeed - 19 Oct 2009
Amgen Provides Update on Status of Prolia(TM) (Denosumab) Biologics License Application (BLA) Submitted to the U.S. Food and Drug Administration (FDA)
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Oct 2009
Covidien Announces Global Launch of Mallinckrodt TaperGuard Line of Endotracheal Tubes
Devices
 HSMN NewsFeed - 16 Oct 2009
Palomar to Commercialize FDA Cleared Over-The-Counter Home Use Wrinkle Treatment Laser Device Without Johnson & Johnson
Devices Dermatology Licensing
 HSMN NewsFeed - 13 Oct 2009
Amarin Announces Changes to Its Board and Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2009
FDA Advisory Committee Recommends Approval of Pfizer's Selzentry for Use in Patients Starting HIV Therapy for the First Time
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 6 Oct 2009
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
Biopharmaceuticals Ophthalmology Drug Delivery Licensing
 HSMN NewsFeed - 2 Oct 2009
Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
Devices Oncology Personnel
 HSMN NewsFeed - 25 Sep 2009
Allos Therapeutics' FOLOTYN First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Sep 2009
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Sep 2009
BurnsAdler Partners With Three Rivers Pharmaceuticals to Commercialize Infergen(R) in Brazil and Chile
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 Sep 2009
Coherex Medical Signs Exclusive Distribution Agreement with Abbott
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 22 Sep 2009
Denosumab Demonstrates Superiority Over Zometa(R) in Delay of Complications Due to Bone Metastases in Advanced Breast Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Sep 2009
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Sep 2009
Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Sep 2009
GENova Biotherapeutics prepares a 510(k) submission to the FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Sep 2009
Delcath Systems, Inc. Appoints David McDonald Chief Financial Officer
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 24 Aug 2009
New Data Demonstrate Magnetic Resonance Safety of AQUACEL(R) Ag Dressing
Devices Wound Care Radiology
 HSMN NewsFeed - 20 Aug 2009
Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
Devices Interventional
 HSMN NewsFeed - 17 Aug 2009
AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 14 Aug 2009
Embrella Cardiovascular, Inc. Announces Final Closing of Series B Round
Devices Interventional Venture Capital
 HSMN NewsFeed - 13 Aug 2009
Constellation Pharmaceuticals, Inc. Appoints Mark A. Goldsmith, M.D., Ph.D. as CEO and Closes $17 Million in Funding
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 13 Aug 2009
Covidien Announces Iowa Health System's Conversion to the Nellcor OxiMax Pulse Oximetry System
Devices Monitoring
 HSMN NewsFeed - 13 Aug 2009
Constellation Pharmaceuticals, Inc. Appoints Mark A. Goldsmith, M.D., Ph.D. as CEO and Closes $17 Million in Funding
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 27 Jul 2009
Ceragenix and MEGAPHARM Enter Into Distribution and Supply Agreement for EpiCeram(R)
Biopharmaceuticals Dermatology Distribution
 HSMN NewsFeed - 17 Jul 2009
NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2009
ICU Medical, Inc. to Acquire Hospira's Critical Care Product Line
Devices Acquisitions
 HSMN NewsFeed - 6 Jul 2009
Eamonn Hobbs Appointed President & CEO of Delcath Systems, Inc.
Devices Drug Delivery Oncology Personnel
 HSMN NewsFeed - 1 Jul 2009
Eisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Jun 2009
Gore Receives FDA Approval for Modification of GORE VIABAHN® Endoprosthesis
Devices Interventional FDA
 HSMN NewsFeed - 22 Jun 2009
NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)
Biopharmaceuticals Drug Delivery Distribution
 HSMN NewsFeed - 10 Jun 2009
FDA Classifies Previously Announced Medtronic Physician Advisory on Small Subset of Kappa and Sigma Pacemakers as Class I Recall
Devices Cardiology Product Recall
 HSMN NewsFeed - 10 Jun 2009
NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 8 Jun 2009
Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Devices Interventional FDA
 HSMN NewsFeed - 2 Jun 2009
NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 Jun 2009
Delcath Systems Granted Third Orphan Drug Designation
Biopharmaceuticals Devices Drug Delivery Oncology FDA
 HSMN NewsFeed - 27 May 2009
Covidien Launches Alarm Management System for the Nellcor(TM) OxiMax(TM) N-600x(TM) Pulse Oximeter
Devices Monitoring
 HSMN NewsFeed - 21 May 2009
NeurogesX Receives European Commission Approval for Qutenza(TM)
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 20 May 2009
Pathway Medical Technologies Closes $42.5M Series D Financing; Announces New Investment From WRF Capital
Devices Venture Capital
 HSMN NewsFeed - 13 May 2009
Monitoring System Stops Hospital Infections with Traffic Light Camera to Capture Hand Hygiene Violators
Devices
 HSMN NewsFeed - 13 May 2009
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 May 2009
Sadra Medical Raises $30 Million
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 5 May 2009
Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 30 Apr 2009
FDA Approves Dysport(TM) for Therapeutic and Aesthetic Uses
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Apr 2009
Covidien Launches Alarm Management System for the Nellcor OxiMax N-600x Pulse Oximeter
Devices Monitoring
 HSMN NewsFeed - 15 Apr 2009
INTEGRA Dermal Regeneration Template Launched in Japan
Devices Wound Care
 HSMN NewsFeed - 9 Apr 2009
NMT Medical Receives PMA Approval for STARFlex as a Ventricular Septal Defect Repair Implant
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 26 Mar 2009
Atritech Completes $30 Million Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 19 Mar 2009
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
Biopharmaceuticals Pain Management Regulatory
 HSMN NewsFeed - 17 Mar 2009
Cardinal Health Launches New Products for the Operating Room
Devices Surgery
 HSMN NewsFeed - 11 Mar 2009
Female Health Company Receives FDA Approval for FC2 Female Condom(R)
Devices FDA
 HSMN NewsFeed - 9 Mar 2009
DiaMedica Appoints Stephen J. Waters as Interim Chief Scientific Officer
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 2 Mar 2009
Lilly Announces Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2009
Power Medical Interventions, Inc. Receives $2.5M Payment From Intuitive Surgical, Inc.
Devices Surgery Licensing
 HSMN NewsFeed - 3 Feb 2009
Warner Chilcott Announces Agreement to Acquire Topical Alprostadil Treatment for Erectile Dysfunction
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 29 Jan 2009
DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 Jan 2009
The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company
Devices Venture Capital Personnel
 HSMN NewsFeed - 21 Jan 2009
Novel Product for Post Surgical Scar Formation Entering Clinical Development
Biopharmaceuticals Surgery
 HSMN NewsFeed - 21 Jan 2009
Panacos Announces Sale of Bevirimat
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 20 Jan 2009
Given Imaging Announces Expansion of Distribution Relationship With FUJIFILM
Devices Gastroenterology Distribution
 HSMN NewsFeed - 15 Jan 2009
ADHEZION BIOMEDICAL ANNOUNCES CE MARK APPROVAL OF FILM-FORMING MICROBIAL SEALANT FLORASEAL(TM)
Devices Surgery Regulatory
 HSMN NewsFeed - 31 Dec 2008
China Medical Technologies Announces the Completion of the Sale of its HIFU Business
Devices Acquisitions
 HSMN NewsFeed - 19 Dec 2008
Amgen Submits Biologics License Application for FDA Approval of Denosumab in Women With Postmenopausal Osteoporosis and in Patients Undergoing Hormone Ablation for Either Prostate or Breast Cancer
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2008
Minimally Invasive Surgery: Olympus Further Enhances Credentials by Entering Into Exclusive Sales and Distribution Partnership With Market and Technology Leader Advanced Surgical Concepts
Devices Distribution
 HSMN NewsFeed - 20 Nov 2008
New Guide System Provides for Consistent, Accurate Portal Placement During Hip Surgery
Devices Orthopaedic
 HSMN NewsFeed - 18 Nov 2008
Delcath Systems Granted Orphan-Drug Designations for Cutaneous and Ocular Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Oct 2008
Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals
 HSMN NewsFeed - 23 Oct 2008
OXiGENE, Inc. Names John A. Kollins as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Oct 2008
Derma Sciences Announces Commercial Launch of XTRASORB(TM)
Devices Wound Care
 HSMN NewsFeed - 8 Oct 2008
Calistoga Pharmaceuticals Appoints Carol G. Gallagher, Pharm. D., Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2008
Biolex Therapeutics Enters Into Agreement to Acquire Full Locteron(R) Commercial Rights
Biopharmaceuticals
 HSMN NewsFeed - 3 Oct 2008
deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 1 Oct 2008
Advanced Life Sciences Announces NDA Submission for Cethromycin in Community Acquired Pneumonia
Biopharmaceuticals
 HSMN NewsFeed - 17 Sep 2008
Merck & Co., Inc. Discontinues License and Research Collaboration Agreement with SurModics
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 17 Sep 2008
Amarin Appoints Dr. Paresh Soni as SVP and Head of Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2008
Denosumab Osteoporosis Trial Finds Patients Transitioned from Alendronate (Fosamax(R)) to Denosumab Achieved Significantly Greater Gains in Bone Mineral Density versus Those Continuing on Alendronate
Biopharmaceuticals
 HSMN NewsFeed - 5 Sep 2008
Digirad Corporation Developing New Cardiac Imaging System With Distortion Correction
Devices Radiology Cardiology
 HSMN NewsFeed - 4 Sep 2008
Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
Biopharmaceuticals
 HSMN NewsFeed - 3 Sep 2008
Derma Sciences Announces Launch Plan for MOBILITY1(TM) Intermittent Compression Therapy Device
Devices
 HSMN NewsFeed - 3 Sep 2008
Natus Medical to Acquire NeuroCom International
Devices Mergers & Acquisitions
 HSMN NewsFeed - 27 Aug 2008
Derma Sciences Announces Latest Exclusive Technology Distribution Agreement
Devices Wound Care Distribution
Return to NewsFeed  

 Additional items found! 495

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 495 additional stories matching:
Enterin
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.